August 25th 2011
Flaxseed had no effect on reducing hot flashes in postmenopausal women who reported experiencing 28 or more hot flashes per week.
August 22nd 2011
In postmenopausal diabetic women, metformin use was associated with lower ER and PR breast cancer incidence.
August 19th 2011
Patients with breast cancer who undertook yoga following radiotherapy derived physical and emotional benefi ts from the ancient Indian practice, according to research presented at ASCO.
August 17th 2011
Breast cancer survivors who stop working during chemotherapy may face the loss of long-term employment for several years after their diagnosis.
August 16th 2011
A randomized trial comparing survivorship care plans with standard oncologist discharge visits in patients with breast cancer found no differences in outcomes among the groups.
August 2nd 2011
Previously unknown genetic methylation patterns and new mutations for squamous cell carcinoma of the head and neck discovered.
July 26th 2011
Adding oxaliplatin to 5-fluorouracil before and after surgery for the treatment of locally advanced rectal cancer is demonstrating significant benefit.
June 7th 2011
Women who present with BRCA1 and BRCA2 mutation face an increased risk of breast and ovarian cancer.
Phosphatase and tensin homolog (PTEN)-positive breast cancer can be treated with trastuzumab (Herceptin) as effectively as PTEN-negative breast cancer
June 6th 2011
3 years of treatment with imatinib (Gleevec) after surgery in patients with high-risk GIST improved overall and recurrence-free survival
Continuation maintenance with pemetrexed (Alimta) improves progression-free survival in patients with advanced nonsquamous non–small cell lung cancer
June 5th 2011
The combination of the MEK inhibitor GSK212 and the oral BRAF inhibitor GSK436 resulted in anti-tumor activity in patients with advanced melanoma
Taking a page from breast cancer treatment, clinicians managing lung cancer patients can now detect mutations that drive the development of lung cancer
Metastatic breast cancer patients with demonstrated disease progression after taxane therapy face an uphill battle in fighting their disease.